LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

LLY

724.75

-2.78%↓

JNJ

153.19

-0.27%↓

ABBV

181.66

-1.71%↓

NVO

68.18

+0.09%↑

UNH

303.28

-5.72%↓

Repligen Corp

Затворен

СекторЗдравеопазване

120.38 -5.57

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

119.98

Максимум

127.55

Ключови измерители

By Trading Economics

Приходи

40M

5.8M

Продажби

1.6M

169M

P/E

Средно за сектора

466.89

56.602

EPS

0.39

Марж на печалбата

3.446

Служители

1,778

EBITDA

2.7M

36M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+42.06% upside

Дивиденти

By Dow Jones

Следващи печалби

29.07.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-718M

7.5B

Предишно отваряне

125.95

Предишно затваряне

120.38

Настроения в новините

By Acuity

50%

50%

179 / 382 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

Repligen Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

20.05.2025 г., 20:54 ч. UTC

Придобивния, сливания и поглъщания

PNC to Buy Private-Equity Agent Aqueduct Capital

20.05.2025 г., 20:50 ч. UTC

Печалби

Palo Alto Networks Posts Higher 3Q Sales, Profit Slips

20.05.2025 г., 23:48 ч. UTC

Придобивния, сливания и поглъщания

Kraft Heinz Evaluating Strategic Transactions, Berkshire Hathaway Steps Away From Board -- Update

20.05.2025 г., 23:42 ч. UTC

Пазарно говорене

Nikkei May Trade Rangebound Amid Tariff Uncertainty -- Market Talk

20.05.2025 г., 23:39 ч. UTC

Пазарно говорене

Gold Steady, Supported by Lingering U.S. Fiscal-Deficit Concerns -- Market Talk

20.05.2025 г., 23:08 ч. UTC

Пазарно говорене

James Hardie's Repair & Remodel Outlook Surprises RBC -- Market Talk

20.05.2025 г., 22:46 ч. UTC

Придобивния, сливания и поглъщания

Gold Road: Takeover Remains Subject to Independent Expert Findings; Shareholder, Court Approval

20.05.2025 г., 22:45 ч. UTC

Придобивния, сливания и поглъщания

Gold Road: Notified Australia Government Has No Objections to Takeover by Gold Fields

20.05.2025 г., 22:44 ч. UTC

Топ новини

Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- 2nd Update

20.05.2025 г., 22:20 ч. UTC

Топ новини

In Latest EV Pullback, Ford to Share Battery Plant With Nissan -- WSJ

20.05.2025 г., 22:00 ч. UTC

Печалби

ZTO Express (Cayman) 1Q Adj EPS 37c >ZTO

20.05.2025 г., 22:00 ч. UTC

Печалби

ZTO Express (Cayman) 1Q EPS 34c >ZTO

20.05.2025 г., 22:00 ч. UTC

Печалби

ZTO Express (Cayman) 1Q Rev $1.5B >ZTO

20.05.2025 г., 21:44 ч. UTC

Печалби

James Hardie Industries 4Q Adj EPS 36c >JHX

20.05.2025 г., 21:44 ч. UTC

Печалби

James Hardie Industries: Sees FY26 North America Net Sales Growth Up Low Single Digits >JHX

20.05.2025 г., 21:44 ч. UTC

Печалби

James Hardie Industries 4Q EPS 10c >JHX

20.05.2025 г., 21:44 ч. UTC

Печалби

James Hardie Industries 4Q Sales $972M >JHX

20.05.2025 г., 20:52 ч. UTC

Топ новини

Elon Musk to Cut Back Political Spending -- 3rd Update

20.05.2025 г., 20:52 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

20.05.2025 г., 20:52 ч. UTC

Пазарно говорене

Mexican Stocks Near Record High As Trade Concerns Ease -- Market Talk

20.05.2025 г., 20:30 ч. UTC

Придобивния, сливания и поглъщания

PNC Financial: Aqueduct Acquisition Expected to Close in Mid-Summer, Terms Won't be Disclosed >PNC

20.05.2025 г., 20:28 ч. UTC

Придобивния, сливания и поглъщания

PNC Bank Agrees To Acquire Aqueduct Capital Group To Complement Harris Williams Capabilities >PNC

20.05.2025 г., 20:23 ч. UTC

Придобивния, сливания и поглъщания

Tesla CEO Musk Says He Plans to Be at White House for a Couple Days Every Few Weeks

20.05.2025 г., 20:22 ч. UTC

Печалби

XP 1Q Adj EPS BRL2.29 >XP

20.05.2025 г., 20:22 ч. UTC

Печалби

XP 1Q Rev BRL4.345B >XP

20.05.2025 г., 20:21 ч. UTC

Придобивния, сливания и поглъщания

Tesla CEO Musk: 'We're in the Big Bang of Intelligence Explosion'

20.05.2025 г., 20:20 ч. UTC

Топ новини

Fed's Bostic Signals Longer Delay in Cutting Interest Rates -- Barrons.com

20.05.2025 г., 20:19 ч. UTC

Придобивния, сливания и поглъщания

Tesla CEO Musk Says He Doesn't Currently Have Plans to Merge Tesla, xAI

20.05.2025 г., 20:11 ч. UTC

Топ новини

Venezuela Frees U.S. Air Force Veteran in Overture to Trump -- Update

20.05.2025 г., 20:09 ч. UTC

Печалби

Palo Alto Networks 3Q Remaining Performance Obligation $13.5 B >PANW

Сравнение с други в отрасъла

Ценова промяна

Repligen Corp Прогноза

Ценова цел

By TipRanks

42.06% нагоре

12-месечна прогноза

Среден 181.25 USD  42.06%

Висок 207 USD

Нисък 150 USD

Според 15 анализатори от Wall Street, предложили 12-месечна ценова цел за Repligen Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

15 ratings

10

Купи

5

Задържане

0

Продай

Техническа оценка

By Trading Central

125.31 / 140.7Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

Strong Bearish Evidence

Дългосрочен план

Strong Bearish Evidence

Настроение

By Acuity

179 / 382 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.